Today: 2 February 2026
Subscribe
Browse Category

Biotechnology News 24 January 2026 - 31 January 2026

Amgen stock heads into earnings week after ending Kyowa Kirin eczema pact

Amgen stock heads into earnings week after ending Kyowa Kirin eczema pact

New York, Jan 31, 2026, 17:04 EST — Market closed. Amgen shares slipped roughly 0.3% to $341.88 on Friday, barely moving ahead of a busy week packed with catalysts. The biotech is set to unwind its partnership with Japan’s Kyowa Kirin. The near-term setup is crucial as Amgen reports earnings on Tuesday. Investors will focus on which projects the company…
31 January 2026
·····
Thermo Fisher stock slides on 2026 profit outlook as research funding cuts bite — what’s next for TMO

Thermo Fisher stock slides on 2026 profit outlook as research funding cuts bite — what’s next for TMO

New York, January 29, 2026, 19:40 EST — After-hours Shares of Thermo Fisher Scientific Inc fell 2.6% to close at $592.16 on Thursday, dropping more than Danaher, which was down 2.3%, and Agilent, down 0.4%. The decline came after the company forecast 2026 profits below Wall Street expectations and flagged challenges from cuts to U.S. academic research funding. Thermo Fisher…
30 January 2026
·····
Denali Therapeutics stock price rises as FDA freezes rival Regenxbio’s Hunter syndrome gene therapy trials

Denali Therapeutics stock price rises as FDA freezes rival Regenxbio’s Hunter syndrome gene therapy trials

New York, Jan 29, 2026, 15:20 EST — Regular session • Denali Therapeutics shares climbed in afternoon trading, gaining ground while the broader biotech sector remained flat.• Attention intensified following the FDA’s decision to halt Regenxbio’s rare-disease gene therapy trials.• Investors are now zeroed in on Denali’s FDA timeline for its Hunter syndrome treatment and the data update expected in…
29 January 2026
·····
Thermo Fisher (TMO) stock slides into earnings — here’s what Wall Street is watching

Thermo Fisher (TMO) stock slides into earnings — here’s what Wall Street is watching

New York, Jan 28, 2026, 21:41 EST — Market closed. Thermo Fisher Scientific (TMO) shares dropped 2.55%, closing at $608.02 on Wednesday. The stock slipped for the second day as investors positioned ahead of the upcoming quarterly report. Trading volume reached around 2.3 million shares, surpassing the 50-day average. The stock now sits about 5.6% below its 52-week peak from…
29 January 2026
·····
BiomX stock jumps in premarket after SEC filing flags new 19.99% holder

BiomX stock jumps in premarket after SEC filing flags new 19.99% holder

New York, Jan 27, 2026, 05:34 EST — Premarket BiomX Inc shares jumped roughly 65% to $6.77 in premarket action Tuesday, even hitting $8.34 earlier, after news surfaced that a new investor snapped up nearly a 20% stake. (Webull) This matters since BiomX is a microcap biotech with a thin tape. With one major holder hovering just below a crucial…
27 January 2026
····
Gilead (GILD) stock hits fresh 52-week high as new analyst targets and CEO sale filing land

Gilead (GILD) stock hits fresh 52-week high as new analyst targets and CEO sale filing land

New York, Jan 26, 2026, 21:14 EST — Market closed Gilead Sciences Inc shares climbed 1.36%, ending Monday at $137.78—a new 52-week peak and marking the stock’s fourth consecutive day of gains. Volume topped the usual levels as Gilead outperformed Johnson & Johnson, Pfizer, and Abbott Laboratories, all while U.S. indexes moved higher. (MarketWatch) With U.S. markets closed overnight, the…
27 January 2026
····
Moderna (MRNA) stock slips; Feb. 13 earnings call is the next catalyst for the share price

Moderna (MRNA) stock slips; Feb. 13 earnings call is the next catalyst for the share price

New York, Jan 26, 2026, 16:37 EST — After-hours Moderna, Inc. shares closed Monday down 1.5% at $47.98. In after-hours trading, which follows the 4 p.m. close, the stock held steady around $47.99. (Investing) The vaccine maker announced Monday it will release its fourth-quarter 2025 results on Feb. 13, followed by a conference call and webcast at 8 a.m. ET.…
26 January 2026
·····
Thermo Fisher Scientific stock rises toward $631 as TMO heads into Jan. 29 earnings

Thermo Fisher Scientific stock rises toward $631 as TMO heads into Jan. 29 earnings

New York, January 26, 2026, 13:10 EST — Regular session underway Shares of Thermo Fisher Scientific Inc climbed on Monday, with TMO trading up 0.8% at $631.24 by midday in New York. The stock started the day lower, fluctuating between $623.51 and $631.36. Thermo Fisher now trades roughly 2% under its 52-week peak of $643.99, following a near 10% rally…
26 January 2026
·····
Amgen stock price slips from record close as AMGN heads into earnings and the obesity-drug race

Amgen stock price slips from record close as AMGN heads into earnings and the obesity-drug race

New York, Jan 25, 2026, 15:31 EST — The market has closed. Amgen shares ended Friday down 0.7% at $344.75, pulling back after a run that nearly took the biotech giant to record highs ahead of the weekend. About 3.8 million shares changed hands, LSEG data shows. This matters as Amgen (AMGN.O) has turned into a popular “defensive growth” pick…
25 January 2026
····
Voyager Technologies stock jumps again on ISS drug-discovery deal, Wedbush call — what to watch next

Voyager Technologies stock jumps again on ISS drug-discovery deal, Wedbush call — what to watch next

New York, Jan 25, 2026, 09:24 EST — Market closed Shares of Voyager Technologies Inc closed Friday up 7.4% at $37.09, after fluctuating between $34.62 and $38.84. Trading volume hovered near 3.0 million shares. The stock continues to act like a fresh IPO: sharp swings, little tolerance, and a market hungry for confirmation. At the moment, traders are focusing on…
25 January 2026
···
ImmunityBio stock tumbles after glioblastoma update; what to watch before Monday

ImmunityBio stock tumbles after glioblastoma update; what to watch before Monday

New York, Jan 25, 2026, 05:38 EST — Market closed ImmunityBio, Inc. (IBRX) shares closed Friday down 12.1% at $6.45, having traded as high as $7.88 and as low as $6.43 amid heavy volume. (Yahoo Finance) This move is significant since the stock’s been riding momentum, but Friday’s pullback hands control back to next week’s data releases. Monday’s open will…
25 January 2026
·······
CRISPR Therapeutics stock drops 9% after CEO sale filing — what CRSP investors watch next week

CRISPR Therapeutics stock drops 9% after CEO sale filing — what CRSP investors watch next week

NEW YORK, Jan 24, 2026, 05:05 EST — Market closed CRISPR Therapeutics AG shares dropped 8.7% on Friday, ending the day at $55.52. The stock moved sharply between $61.01 and $55.07 during a choppy session that saw roughly 2.4 million shares change hands. This shift is significant since CRSP is acting like a story stock despite having a tangible product…
24 January 2026
····
1 2 3 … 24

Stock Market Today

  • Euronext Expands Governance Services in France with Admincontrol Tools
    February 2, 2026, 5:39 AM EST. Euronext has introduced Admincontrol's governance and secure collaboration software in France, enhancing digital tools for listed and private companies. This move follows Euronext's acquisition of Admincontrol in May 2025. The solutions focus on helping French firms comply with tightening regulations and uphold GDPR and European data sovereignty. Features include a secure board portal, a board evaluation module for listed firms, and a secure data room for IPOs and mergers. Mathieu Caron, Head of Primary Markets, highlighted the emphasis on local support and data security amid changing rules. Julien Tessier, CEO of Euronext Corporate Solutions, said the launch raises the bar for governance efficiency and strategic focus in French markets.
Go toTop